Vertex Pharmaceuticals Incorporated

Financials

Flusso di cassa derivante dalle attività operative 3.25 B2.64 B4.13 B3.54 B-492.6 M3.63 B 3.63 B Flussi di cassa derivanti dalle attività di investimento 99.39 M-340.9 M-321.1 M-3.14 B-3.77 B-945.4 M -945.4 M Liquidità derivante dalle attività di finanziamento -505.28 M-1.48 B-67.7 M-562.2 M-1.49 B-2.26 B -2.26 B Liquidità libera 2.99 B2.41 B3.93 B3.28 B-790.3 M3.19 B 3.19 B

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

VRTX

Financials

Vertex Pharmaceuticals Incorporated

Notizie

Argenx e Vertex Pharmaceuticals scelte da BofA come top pick biotech per il 2026

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

What to Expect From Vertex Pharmaceuticals’ Q1 2026 Earnings Report

Undercovered Dozen: CVR Energy, Greystone Housing, Conagra Brands, And More

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Halozyme concede in licenza la tecnologia Hypercon a Vertex per 15 milioni di dollari

Leerink conferma il rating su Halozyme dopo l’accordo con Vertex

William Blair conferma il rating su Amgen dopo i dati positivi su Tepezza

Vertex Pharmaceuticals: Label Expansions For ALYFTREK & TRIKAFTA Plus Strong Demand (VRTX)

RBC Capital conferma il rating su Amgen per la crescita diversificata